Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks
Completed · Phase 2
Conditions studied: Edematous Fibrosclerotic Panniculopathy, Cellulite
In brief
The study will evaluate the effect of different doses, strengths (concentrations), diluent additives, depths of injection, and methods of injection on the severity of bruising potentially induced by QWO (collagenase clostridium histolyticum-aaes \[CCH-aaes\]).
Key facts
- Study ID
- NCT05419505
- Run by
- Endo USA Inc., a Keenova Therapeutics Company
- People needed
- 91
- Starts
- 2022-06-15
- Expected to finish
- 2023-06-21
- Last updated by the study team
- 2025-03-07
Who can join
Age: 18 and older, up to 60. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Endo Clinical Trial Site #6 — Scottsdale, Arizona, United States
- Endo Clinical Trial Site #4 — Beverly Hills, California, United States
- Endo Clinical Trial Site #9 — Encinitas, California, United States
- Endo Clinical Trial Site #10 — San Diego, California, United States
- Endo Clinical Trial Site #7 — Solana Beach, California, United States
- Endo Clinical Trial Site #12 — Greenwood Village, Colorado, United States
- Endo Clinical Trial Site #8 — Coral Gables, Florida, United States
- Endo Clinical Trial Site #13 — Miami, Florida, United States
- Endo Clinical Trial Site #3 — Chicago, Illinois, United States
- Endo Clinical Trial Site #2 — Metairie, Louisiana, United States
- Endo Clinical Trial Site #11 — New York, New York, United States
- Endo Clinical Trial Site #1 — Nashville, Tennessee, United States
- Endo Clinical Trial Site #5 — Pflugerville, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.